Stocks

Beam Therapeutics BEAM

Health care sectorNasdaq

What to see in Beam Therapeutics now

Is Wall Street adding or cutting?+24

277 13F filers hold it · +24 against the quarter before · shares held +1.0%

Holdings of 06/30
Who bought more than 5%?9.9%

ARK Investment Management holds 9.95% · −2.3pp on the report before

Filed 08/14
What comes next?10/15 (Thu)

10/15 estimated earnings

Due 10/15
Close
$24.44
09/30 close
Day change
−0.3%
vs previous close
Volume
74,700
−12.4% vs 30-day average
52-week range
$20.23$37.98
1-year return
+0.3%
vs the close a year ago
Market cap
$2.5B
103,287,665 shares · reported 07/28

Company

Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, Massachusetts
Fiscal year end
12/31
Next earnings
10/15, estimated
  • 277 13F filers hold it · +24 against the quarter before · shares held +1.0%Holdings of 06/30
  • ARK Investment Management holds 9.95% · −2.3pp on the report beforeFiled 08/14

Funds

13F filers: 277 · +24 since the quarter before · 06/30 holdings

Famous funds that held Beam Therapeutics in their latest 13F report.

FundValueSince the quarter before
ARK Investment ManagementBeam Therapeutics BEAM · 06/30 holdings$351.3MTrimmed −15.6%
Mirae Asset Global ETFS HoldingsBeam Therapeutics BEAM · 06/30 holdings$5.4MNo quarter before
Mirae Asset Global InvestmentsBeam Therapeutics BEAM · 06/30 holdings$157.9KTrimmed −13.4%
Duquesne Family OfficeBeam Therapeutics BEAM · 06/30 holdings$5,272New position
All tracked funds

5% stakes

Holder
ARK Investment Management08/149.95%10,234,862 sh−2.3pp
Vanguard Capital Management04/295.02%5,122,475 shFirst report
State Street02/095.2%5,228,529 shFirst report
FMR02/0512.6%12,750,369.42 sh−1.0pp
ARK Investment Management02/0312.29%12,467,189 sh+1.9pp
FMR25/11/0513.6%13,766,517.7 sh−1.4pp
ARK Investment Management25/08/0710.35%10,410,137 sh+2.4pp
FMR25/08/0615%15,083,498.08 sh+4.9pp
Arch Venture Fund IX25/05/154.6%4,600,747 sh−1.0pp
FMR25/04/0210.1%10,042,092.33 sh+3.5pp
All 5% stake reports on Beam Therapeutics

Price

$24.44Day −0.3%1 year +0.3%

26-week trading